These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31843839)

  • 1. Door-to-needle time for thrombolysis: a secondary analysis of the TIPS cluster randomised controlled trial.
    Hasnain MG; Paul CL; Attia JR; Ryan A; Kerr E; D'Este C; Hall A; Milton AH; Hubbard IJ; Levi CR
    BMJ Open; 2019 Dec; 9(12):e032482. PubMed ID: 31843839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Access to Thrombolysis and Inhospital Management Times in Ischemic Stroke: A Stepped-Wedge Randomized Trial.
    Haesebaert J; Nighoghossian N; Mercier C; Termoz A; Porthault S; Derex L; Gueugniaud PY; Bravant E; Rabilloud M; Schott AM;
    Stroke; 2018 Feb; 49(2):405-411. PubMed ID: 29321338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic.
    Chen Y; Nguyen TN; Wellington J; Mofatteh M; Yao W; Hu Z; Kuang Q; Wu W; Wang X; Sun Y; Ouyang K; Xu J; Huang W; Yang S
    J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106179. PubMed ID: 34735901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cluster-Randomized Trial of Thrombolysis Implementation Support in Metropolitan and Regional Australian Stroke Centers: Lessons for Individual and Systems Behavior Change.
    Levi CR; Attia JA; D'Este C; Ryan AE; Henskens F; Kerr E; Parsons MW; Sanson-Fisher RW; Bladin CF; Lindley RI; Middleton S; Paul CL; ;
    J Am Heart Assoc; 2020 Feb; 9(3):e012732. PubMed ID: 31973599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke.
    Raina A; Trivedi M; Kate M; Kumar L; Erat Sreedharan S; Sylaja PN
    J Clin Neurosci; 2020 Apr; 74():164-167. PubMed ID: 32094070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving a door-to-needle time of 25 minutes in thrombolysis for acute ischemic stroke: a quality improvement project.
    Van Schaik SM; Van der Veen B; Van den Berg-Vos RM; Weinstein HC; Bosboom WMJ
    J Stroke Cerebrovasc Dis; 2014; 23(10):2900-2906. PubMed ID: 25263647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis implementation intervention and clinical outcome: a secondary analysis of a cluster randomized trial.
    Hasnain MG; Paul CL; Attia JR; Ryan A; Kerr E; Oldmeadow C; D'Este CA; Bivard A; Hubbard IJ; Milton AH; Levi CR
    BMC Cardiovasc Disord; 2020 Oct; 20(1):432. PubMed ID: 33023494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group study.
    Zonneveld TP; Vermeer SE; van Zwet EW; Groot AED; Algra A; Aerden LAM; Alblas KCL; de Beer F; Brouwers PJAM; de Gans K; van Gemert HMA; van Ginneken BCAM; Grooters GS; Halkes PHA; van der Heijden-Montfroy TAMHG; Jellema K; de Jong SW; Lövenich-Ciccarello H; van der Meulen WDM; Peters EW; van der Ree TC; Remmers MJM; Richard E; Rovers JMP; Saxena R; van Schaik SM; Schonewille WJ; Schreuder TAHCML; de Schryver ELLM; Schuiling WJ; Spaander FH; van Tuijl JH; Visser MC; Zinkstok SM; Zock E; Dippel DWJ; Kappelle LJ; van Oostenbrugge RJ; Roos YBWEM; Vermeij FH; Wermer MJH; van der Worp HB; Nederkoorn PJ; Kruyt ND
    Lancet Neurol; 2024 Aug; 23(8):807-815. PubMed ID: 38763149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the implementation of a 24-hr stroke thrombolysis emergency treatment for patients with acute ischaemic stroke.
    Zhao J; Li X; Liang Y; Zhao L; Zhang X; Liu Y
    J Clin Nurs; 2018 May; 27(9-10):2161-2167. PubMed ID: 29345016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Door-to-Needle Time Reduced for Emergency Medical Services Transported Stroke Patients Routed Directly to the Computed Tomography Scanner on Emergency Department Arrival?
    Sloane B; Bosson N; Sanossian N; Saver JL; Perez L; Gausche-Hill M
    J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104477. PubMed ID: 31699573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can a multicomponent multidisciplinary implementation package change physicians' and nurses' perceptions and practices regarding thrombolysis for acute ischemic stroke? An exploratory analysis of a cluster-randomized trial.
    Hasnain MG; Levi CR; Ryan A; Hubbard IJ; Hall A; Oldmeadow C; Grady A; Jayakody A; Attia JR; Paul CL
    Implement Sci; 2019 Nov; 14(1):98. PubMed ID: 31771599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis ImPlementation in Stroke (TIPS): evaluating the effectiveness of a strategy to increase the adoption of best evidence practice--protocol for a cluster randomised controlled trial in acute stroke care.
    Paul CL; Levi CR; D'Este CA; Parsons MW; Bladin CF; Lindley RI; Attia JR; Henskens F; Lalor E; Longworth M; Middleton S; Ryan A; Kerr E; Sanson-Fisher RW;
    Implement Sci; 2014 Mar; 9():38. PubMed ID: 24666591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes.
    Tran D; Zhu Z; Shafie M; Abcede H; Stradling D; Yu W
    BMC Neurol; 2019 Nov; 19(1):300. PubMed ID: 31771530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
    Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an intrahospital mobile thrombolysis team on 3-month clinical outcomes in patients benefiting from intravenous thrombolysis for acute ischemic stroke.
    Hebant B; Triquenot-Bagan A; Guegan-Massardier E; Ozkul-Wermester O; Grangeon L; Maltête D
    Rev Neurol (Paris); 2017 Mar; 173(3):152-158. PubMed ID: 28314516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prehospital and Emergency Department-Focused Mission Protocol Improves Thrombolysis Metrics for Suspected Acute Stroke Patients.
    Madhok DY; Keenan KJ; Cole SB; Martin C; Hemphill JC
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104423. PubMed ID: 31606319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of emergency medicine pharmacists in stroke thrombolysis: A cohort study.
    Roman C; Cloud G; Dooley M; Mitra B
    J Clin Pharm Ther; 2021 Aug; 46(4):1095-1102. PubMed ID: 33751617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.